Microbot Medical Inc. — Director's Dealing 2025

Feb 7, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Microbot Medical Inc. (MBOT)
CIK: 0000883975
Period of Report: 2025-02-05

Reporting Person: Diaz-Cartelle Juan (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-05	Stock Option (Right to Buy)	$2.04	A	42000	Acquired	2035-02-05	Common Stock, par value $0.01 per share (42000)	Direct
2024-02-26	Stock Option (Right to Buy)	$1.25	A	10500	Acquired	2034-02-26	Common Stock, par value $0.01 per share (10500)	Direct

Footnotes

F1: The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the "Plan"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan.

F2: Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 10,500 options have been met and, accordingly, vested.